Grantham, Mayo, Van Otterloo & Co (GMO)
ABT icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Abbott ABT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-173,800
Closed -$6.83M – 507
2016
Q2 		$6.83M Buy
+173,800
New +$6.92M 0.03% 268

Other funds holding ABT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s ABT Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Abbott (ABT) stake by 1.3% in Q2 2026, selling an estimated $10.7M and leaving 8,794,077 shares worth $798M. The position accounts for 1.8% of the portfolio, ranked #19.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ABT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.1B in Q3 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 8,794,077 shares of Abbott worth $798M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 116,868 Abbott shares in Q2 2026, an estimated $10.7M.
  • Abbott made up 1.8% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #19 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Abbott in Q2 2013 and has held it in 53 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Abbott position peaked at $1.1B in Q3 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.